Copyright
        ©The Author(s) 2023.
    
    
        World J Hepatol. Apr 27, 2023; 15(4): 515-524
Published online Apr 27, 2023. doi: 10.4254/wjh.v15.i4.515
Published online Apr 27, 2023. doi: 10.4254/wjh.v15.i4.515
            Table 1 Application of various minimally invasive treatments in hepatocellular carcinoma
        
    | Tumour size | Patients condition | Treatment | 
| Sub-centimeter | Percutaneous tumors | PRFA | 
| Local ablation therapy is not feasible | TACE | |
| < 3 cm | Percutaneous tumors | PRFA | 
| Subphrenic and subcapsular tumors | LRFA | |
| Perivascular tumors | MWA | |
| Can't endure thermal ablation | CRA | |
| MVI (+) | TACE-RFA | |
| 3-5 cm | With liver function compensation | TACE-RFA | 
| Liver failure | MWA, CRA | 
- Citation: Wang L, Liu BX, Long HY. Ablative strategies for recurrent hepatocellular carcinoma. World J Hepatol 2023; 15(4): 515-524
- URL: https://www.wjgnet.com/1948-5182/full/v15/i4/515.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i4.515

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        